ALOXI® (PALONOSETRON HCL) INJECTION AVAILABLE FOR PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING
[ 2008/07/09 | Eisai Co., Ltd. | Pharmaceuticals | Tokyo | TSE1(PRIME) ]

The Company's Official Page
http://www.eisai.co.jp/enews/enews200842.html
Back To Previous Page
Dear User,
JPubb program could not collect the texts of this press-release from the official page, which perhaps mainly comprises tables, charts or images. Please refer to the official page indicated above. -- by JPubb

Latest News: Pharmaceuticals

    この内容でのリリース掲載はまだ無いか、集計されておりません。

more
    この内容でのリリース掲載はまだ無いか、集計されておりません。

more

Most Popular: Pharmaceuticals

1. Co-Promotion Agreement of "FOSAMAC&...
Hisamitsu Pharmaceutical Co., Inc. 2009/01/23
2. Kaken Pharmaceutical and Taiyo Yakuhin E...
Kaken Pharmaceutical Co.,Ltd. 2004/04/27
3. KAKEN PHARMACEUTICAL Start Operations of...
Kaken Pharmaceutical Co.,Ltd. 2002/03/26
4. KAKEN PHARMACEUTICAL CO., LTD. and the I...
Kaken Pharmaceutical Co.,Ltd. 2000/12/14
5. ALOXI® (PALONOSETRON HCL) INJECTION...
Eisai Co., Ltd. 2008/07/09

Latest News: Eisai Co., Ltd.


more

Most Popular: Eisai Co., Ltd.

1. E7389 Demonstrated Anti-tumor Activity i...
2008/05/16
2. HUMIRA® received approval for the t...
2008/04/16

Categories

Go to Page Top

View: Smartphone | PC

Language: English | Japanese

■Home

■Terms & Conditions

■Twitter ■Facebook

■About Us